Chong Kun Dang Pharmaceutical185750
Chong Kun Dang Pharmaceutical (185750) Preliminary Earnings, 2026-10-30
Filing date ·
Chong Kun Dang Pharmaceutical reported preliminary Q3 2026 results (separate): Revenue of KRW 430.7 billion (+0.8% year over year), operating profit of KRW 23.…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.